SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 137 filers reported holding SUTRO BIOPHARMA INC in Q4 2020. The put-call ratio across all filers is 0.60 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $4,192,000 | -24.7% | 281,702 | -4.5% | 0.46% | -1.5% |
| Q3 2021 | $5,569,000 | +1.6% | 294,825 | 0.0% | 0.47% | +26.1% |
| Q2 2021 | $5,481,000 | -18.3% | 294,825 | 0.0% | 0.37% | -28.0% |
| Q1 2021 | $6,710,000 | +53.3% | 294,825 | +46.2% | 0.52% | +32.7% |
| Q4 2020 | $4,377,000 | +14.0% | 201,600 | -52.3% | 0.39% | -34.6% |
| Q3 2019 | $3,841,000 | -24.3% | 422,589 | -5.2% | 0.59% | -14.6% |
| Q2 2019 | $5,074,000 | +1.7% | 445,889 | +1.8% | 0.69% | +52.5% |
| Q1 2019 | $4,988,000 | +35.6% | 437,889 | +7.4% | 0.46% | +9.6% |
| Q4 2018 | $3,679,000 | -10.8% | 407,889 | +48.3% | 0.42% | -12.4% |
| Q3 2018 | $4,125,000 | – | 275,000 | – | 0.47% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 1,675,579 | $13,773,000 | 3.47% |
| AJU IB Investment Co., Ltd. | 175,000 | $1,439,000 | 2.22% |
| Frazier Life Sciences Management, L.P. | 1,776,479 | $14,603,000 | 1.24% |
| First Light Asset Management, LLC | 1,672,497 | $13,748,000 | 1.21% |
| BVF INC/IL | 3,447,946 | $28,342,000 | 1.13% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,732,400 | $30,680,000 | 0.94% |
| Endurant Capital Management LP | 296,508 | $2,437,000 | 0.64% |
| Parkman Healthcare Partners LLC | 199,846 | $1,643,000 | 0.48% |
| Eventide Asset Management | 2,708,975 | $22,268,000 | 0.35% |
| Lombard Odier Asset Management (Switzerland) SA | 391,024 | $3,214,000 | 0.25% |